Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 9 | 2017 | 310 | 1.890 |
Why?
|
Breast Neoplasms | 9 | 2018 | 1536 | 1.130 |
Why?
|
Ultrasonography, Mammary | 5 | 2015 | 39 | 1.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 772 | 0.810 |
Why?
|
Breast Density | 3 | 2017 | 21 | 0.760 |
Why?
|
Radiology | 3 | 2018 | 97 | 0.700 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2012 | 163 | 0.660 |
Why?
|
Liver Cirrhosis | 2 | 2012 | 301 | 0.620 |
Why?
|
Liver Neoplasms | 2 | 2012 | 334 | 0.590 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 177 | 0.510 |
Why?
|
Graft Rejection | 2 | 2009 | 458 | 0.510 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 237 | 0.480 |
Why?
|
Practice Patterns, Physicians' | 1 | 2017 | 504 | 0.430 |
Why?
|
Ultrasonography, Doppler | 2 | 2009 | 57 | 0.410 |
Why?
|
Biliary Dyskinesia | 1 | 2011 | 7 | 0.400 |
Why?
|
Kidney Transplantation | 2 | 2009 | 839 | 0.370 |
Why?
|
Diagnostic Imaging | 2 | 2008 | 201 | 0.320 |
Why?
|
Kidney Diseases | 2 | 2009 | 307 | 0.320 |
Why?
|
World Health Organization | 1 | 2008 | 53 | 0.310 |
Why?
|
International Classification of Diseases | 1 | 2008 | 85 | 0.310 |
Why?
|
Granular Cell Tumor | 1 | 2008 | 9 | 0.310 |
Why?
|
Abdomen | 1 | 2008 | 80 | 0.300 |
Why?
|
Lymphoma | 1 | 2008 | 116 | 0.290 |
Why?
|
Ultrasonography | 5 | 2012 | 453 | 0.290 |
Why?
|
Observer Variation | 2 | 2018 | 330 | 0.280 |
Why?
|
Breast Diseases | 2 | 2016 | 40 | 0.250 |
Why?
|
Middle Aged | 13 | 2017 | 21147 | 0.240 |
Why?
|
Carcinoma, Small Cell | 1 | 2004 | 53 | 0.240 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2015 | 62 | 0.230 |
Why?
|
Female | 17 | 2018 | 38074 | 0.220 |
Why?
|
Humans | 22 | 2018 | 68618 | 0.220 |
Why?
|
Receptors, Progesterone | 2 | 2013 | 57 | 0.210 |
Why?
|
Receptors, Estrogen | 2 | 2013 | 142 | 0.200 |
Why?
|
Receptor, ErbB-2 | 2 | 2013 | 129 | 0.200 |
Why?
|
Postoperative Complications | 1 | 2009 | 1615 | 0.200 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 1753 | 0.200 |
Why?
|
Positron-Emission Tomography | 2 | 2011 | 160 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 3 | 2015 | 2223 | 0.180 |
Why?
|
Adult | 11 | 2017 | 21403 | 0.170 |
Why?
|
Mass Screening | 2 | 2017 | 843 | 0.160 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 32 | 0.160 |
Why?
|
Carcinoma in Situ | 1 | 2018 | 47 | 0.150 |
Why?
|
Arterial Occlusive Diseases | 2 | 2009 | 134 | 0.150 |
Why?
|
Diagnostic Errors | 1 | 2018 | 100 | 0.150 |
Why?
|
Mobile Health Units | 1 | 2017 | 18 | 0.150 |
Why?
|
Absorptiometry, Photon | 1 | 2016 | 83 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2018 | 383 | 0.130 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 369 | 0.130 |
Why?
|
Reproducibility of Results | 3 | 2016 | 2077 | 0.130 |
Why?
|
Medical Oncology | 1 | 2016 | 110 | 0.130 |
Why?
|
Lung Neoplasms | 1 | 2004 | 1173 | 0.130 |
Why?
|
Guideline Adherence | 1 | 2016 | 287 | 0.120 |
Why?
|
Ovarian Cysts | 1 | 2013 | 9 | 0.120 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2013 | 21 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 1140 | 0.110 |
Why?
|
Aged, 80 and over | 6 | 2016 | 4848 | 0.110 |
Why?
|
Research Design | 1 | 2017 | 729 | 0.110 |
Why?
|
Neoplasm Grading | 1 | 2013 | 111 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 2324 | 0.100 |
Why?
|
Biomarkers, Tumor | 2 | 2013 | 508 | 0.100 |
Why?
|
Sentinel Surveillance | 1 | 2012 | 20 | 0.100 |
Why?
|
Gallbladder Emptying | 1 | 2011 | 4 | 0.100 |
Why?
|
Imino Acids | 1 | 2011 | 7 | 0.100 |
Why?
|
ROC Curve | 1 | 2013 | 392 | 0.100 |
Why?
|
Cholecystokinin | 1 | 2011 | 29 | 0.100 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 267 | 0.100 |
Why?
|
Technetium | 1 | 2011 | 38 | 0.100 |
Why?
|
Aged | 8 | 2017 | 14862 | 0.100 |
Why?
|
Pelvic Pain | 1 | 2011 | 11 | 0.100 |
Why?
|
Ascitic Fluid | 1 | 2009 | 22 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2012 | 800 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 333 | 0.090 |
Why?
|
Paracentesis | 1 | 2009 | 25 | 0.090 |
Why?
|
Ascites | 1 | 2009 | 38 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2011 | 1040 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 1465 | 0.080 |
Why?
|
Rare Diseases | 1 | 2008 | 41 | 0.080 |
Why?
|
Disease Progression | 1 | 2012 | 1038 | 0.080 |
Why?
|
Urethral Obstruction | 1 | 2008 | 8 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2018 | 7277 | 0.080 |
Why?
|
Male | 4 | 2012 | 37321 | 0.080 |
Why?
|
Contrast Media | 1 | 2011 | 595 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2008 | 219 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2008 | 57 | 0.070 |
Why?
|
United States | 2 | 2018 | 7367 | 0.070 |
Why?
|
Chronic Disease | 1 | 2012 | 1330 | 0.070 |
Why?
|
Biopsy | 2 | 2018 | 540 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2007 | 446 | 0.060 |
Why?
|
Abdominal Neoplasms | 1 | 2004 | 22 | 0.060 |
Why?
|
Thoracic Neoplasms | 1 | 2004 | 10 | 0.060 |
Why?
|
Kidney | 1 | 2009 | 945 | 0.060 |
Why?
|
Prospective Studies | 1 | 2011 | 3705 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2004 | 100 | 0.060 |
Why?
|
Brain Neoplasms | 1 | 2004 | 371 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2018 | 35 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2018 | 3259 | 0.040 |
Why?
|
Genetic Testing | 1 | 2018 | 159 | 0.040 |
Why?
|
Premenopause | 1 | 2016 | 57 | 0.030 |
Why?
|
Postmenopause | 1 | 2016 | 93 | 0.030 |
Why?
|
Calcinosis | 1 | 2016 | 241 | 0.030 |
Why?
|
Ovary | 1 | 2013 | 99 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 454 | 0.030 |
Why?
|
Mesenteric Lymphadenitis | 1 | 2011 | 2 | 0.020 |
Why?
|
Ureteral Calculi | 1 | 2011 | 4 | 0.020 |
Why?
|
Diverticulitis | 1 | 2011 | 6 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2011 | 36 | 0.020 |
Why?
|
Appendicitis | 1 | 2011 | 55 | 0.020 |
Why?
|
Colitis | 1 | 2011 | 156 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2011 | 286 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2007 | 64 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 5731 | 0.020 |
Why?
|
Brachytherapy | 1 | 2007 | 79 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2007 | 191 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 2334 | 0.020 |
Why?
|
Child | 1 | 2013 | 6405 | 0.010 |
Why?
|
Adolescent | 1 | 2013 | 8912 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2007 | 7029 | 0.010 |
Why?
|